Sommermeyer, D., Hudecek, M., Kosasih, P. L., Gogishvili, T., Maloney, D. G., Turtle, C. J., & Riddell, S. R. (2015). Chimeric antigen receptor-modified T cells derived from defined CD8(+) and CD4(+) subsets confer superior antitumor reactivity in vivo. Leukemia.

Sommermeyer, Daniel, Michael Hudecek, Paula L. Kosasih, Tea Gogishvili, David G. Maloney, Cameron J. Turtle, and Stanley R. Riddell. "Chimeric Antigen Receptor-modified T Cells Derived From Defined CD8(+) and CD4(+) Subsets Confer Superior Antitumor Reactivity in Vivo." Leukemia 2015.

Sommermeyer, Daniel, et al. "Chimeric Antigen Receptor-modified T Cells Derived From Defined CD8(+) and CD4(+) Subsets Confer Superior Antitumor Reactivity in Vivo." Leukemia 2015.